AS

Asmita Shaileshkumar Patel

Active Director Director DIN 11317320
DIN 11317320 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Asmita Shaileshkumar Patel

Data last updated:

Asmita Shaileshkumar Patel is a Director at Suvexa Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11317320
Primary Designation Director
Industry Pharma
First Appointment 25 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Sep 20252025Active

Board colleagues of Asmita Shaileshkumar Patel

Directorship timeline

Open interactive timeline →
Suvexa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Asmita Shaileshkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Asmita Shaileshkumar Patel

Asmita Shaileshkumar Patel currently holds 1 directorship: Suvexa Pharmaceuticals Private Limited (Director, since 25 Sep 2025).

Asmita Shaileshkumar Patel was first appointed on 25 Sep 2025 as Director at Suvexa Pharmaceuticals Private Limited.

The current boards of Asmita Shaileshkumar Patel's companies include Shaileshkumar Rameshbhai Patel (Suvexa Pharmaceuticals Private Limited), Shivansh Shaileshkumar Patel (Suvexa Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available